Lupus Erythematosus, Systemic - 30 Studies Found
| Active, not recruiting |
: A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus : Lupus Erythematosus, Systemic : 2015-07-17 :
|
| Enrolling by invitation |
: An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults : Lupus Erythematosus, Systemic : 2012-12-17 : Biological: MEDI-546 MEDI-546, IV q4wks for 104 weeks |
| Suspended |
: Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine : Systemic Lupus Erythematosus : 2008-10-17 :
|
| Active, not recruiting |
: Exploratory Study of MT-1303 in Systemic Lupus Erythematosus Patients : Systemic Lupus Erythematosus : 2014-11-18 :
|
| RECRUITING |
: Efficacy and Safety of Telitacicept in Early SLE : : 2024-11-21 : 160mg once a week for 48 weeks |
| RECRUITING |
: Engagement in CHildhood-Onset Systemic Lupus : Lupus Erythematosus, Systemic : 2024-11-21 : Valera mobile health application will provide educational materials around mental health and Systemic Lupus Erythematosus (SLE) and the ability to con |
| RECRUITING |
: Relationship Between Data Obtained With the LuGENE� Multiparameter Transcriptomics Blood Test and Clinical and Standard Laboratory Features of Patients With SLE (ReLATE) : Lupus Erythematosus, Systemic : 2024-11-21 : LuGENE�, a transcriptomic-based LDT, with standard evaluation of patients diagnosed with SLE |
| RECRUITING |
: A Study of CC-97540 in Participants With Severe, Refractory Systemic Lupus Erythematosus (SLE) : Lupus Erythematosus, Systemic : 2024-11-21 : Specified dose on specified days |
| RECRUITING |
: A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms. : Lupus Erythematosus, Systemic : 2024-11-21 : Placebo (intravenous infusion) |
| RECRUITING |
: A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus : Lupus Erythematosus, Systemic : 2024-11-21 : Cenerimod will be supplied as film-coated tablets at the dose of 4 mg. |